EKF Diagnostics Holdings plc is a worldwide manufacturer and distributor of IVD devices, rapid tests and clinical chemistry. The business has specific focuses within near patient care technology for use in the detection and management of diabetes, anaemia, lactate and kidney-related diseases.
From its beginnings in Barleben, Germany in 1990, EKF has grown to become a global in vitro diagnostics business with sites in the UK, Ireland, US and across Europe.
The company’s 2011 acquisition of Stanbio Laboratory expanded its range of in vitro diagnostics analysers and its distribution network, so that currently, EKF Diagnostics has distributors in more than 70 locations around the globe. EKF Diagnostics’ strengths lie in its multi-national research and manufacturing facilities, teams of experienced analysts and engineers in Germany, Ireland, USA and the UK, and a board led by some of world’s foremost authorities in medical diagnostics.
EKF Diagnostics’ expertise covers the entire in vitro diagnostics chain, from fermentation and enzyme production, to the manufacture of liquid reagents, the design and building of world-class diagnostic devices and the distribution of rapid test kits for infectious diseases and pregnancy.
The EKF range of analysers are a trusted brand in physician surgeries, pharmacies, blood banks, sports clinics, hospitals and laboratories for the measurement of glucose, lactate, haemoglobin, haematocrit and HbA1c. In addition, EKF Diagnostics’ wholly owned subsidiary, Argutus Medical, is a worldwide leader in the manufacture and distribution of organ injury biomarkers, specialising in acute injury to the kidneys (AKI), liver and pancreas.
The company goal is to produce analysers and consumables for near-patient care testing that deliver laboratory accuracy and reliability without the high costs and maintenance associated with laboratory devices. EKF’s analysers are designed with technical quality and ease of use an important part of the development process. By delivering results within minutes, or even seconds, EKF is at the forefront of improving the POC testing experience for both healthcare professionals and patients.
• Hemo Control
• STAT-Site M
Glycated haemoglobin (HbA1c) testing
Glucose and lactate testing
• Lactate Scout
• Beta-Hydroxybutyrate (ßHB) LiquiColor reagent
• Acute kidney injury (AKI)
• GST and p-GST Kidney Markers